Evidence map›Paper›PMID 33875938›Full record

ArticleInternational journal of ophthalmology2021

Effect of

Bing Xu, Lei Li, Wei Zhang, Yue Li, Mao-Ren Wang, Jing-Chen Liu, Kai-Ye Dong, Ido Didi Fabian, Dong Qiu, Cai-Rui Li and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Bing XuDepartment of Ophthalmology, Fuling Central Hospital, Chongqing 408000, China.
Lei LiDepartment of Ophthalmology, the First Affiliated Hospital, Dali University, Dali 671000, Yunnan Province, China.
Wei ZhangDepartment of Ophthalmology, Fuling Central Hospital, Chongqing 408000, China.
Yue LiDepartment of Pathology, Fuling Central Hospital, Chongqing 408000, China.
Mao-Ren WangClinical Medicine, Dali University, Dali 671000, Yunnan Province, China.
Jing-Chen LiuClinical Medicine, Dali University, Dali 671000, Yunnan Province, China.
Kai-Ye DongDepartment of Ophthalmology, the First Affiliated Hospital, Dali University, Dali 671000, Yunnan Province, China.
Ido Didi FabianGoldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel-Aviv University, Tel-Aviv 52621, Israel.
Dong QiuClinical Medicine, Dali University, Dali 671000, Yunnan Province, China.
Cai-Rui LiDepartment of Ophthalmology, the First Affiliated Hospital, Dali University, Dali 671000, Yunnan Province, China.
Yi-Min XiangDepartment of Ophthalmology, Fuling Central Hospital, Chongqing 408000, China.
Fuling Center Hospital of Chongqing · CNDali University · CNTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo explore the effect of the

methodsThe refined

resultsInfrared and ultraviolet spectrum scanning showed that the extracted drug was a polysaccharide with high purity. After being treated with different concentrations of

conclusionThe

Indexed as

apoptosiscell cyclecell proliferationretinoblastoma

Identifiers

PMID33875938
PMCPMC8025161
OpenAlexW3149997555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.